Member Info for TonyFawcett

I agree Zoom,
You would have thought Dr Al would have learnt by previous missed deadlines and making predictions with such confidence suckering in small investors. He would be better under promising and over delivering not the other way around like he has been doing.

There’s still tomorrow or Thursday, don’t loose faith. It’s not Avacta who approve CE approval, it’s not their decision , we are working to someone else’s timetable not Avactas.

They want your shares, the sp drop is designed to panic weak holders into selling before the elusive rns. A couple of weeks ago the sp went from £1.90 to £2.80 in a week.

Morning Zoom,
I originally got in sub 50p, my current average is £1.49. I still believe it will happen and happen soon, wether it’s this week is in the lap of the gods. As we have seen before this share can bounce quickly, the last bounce it went from £1.90 to £2.80 within a week. GLA

This was expected when the expectant anticipated RNS did not happen. When Dr Al said by the end of the first quarter in a few weeks only two weeks ago did make me think this guys predictions are not to be trusted or to be taken with a pinch of salt. I hope it does happen this week, but it’s one of them things that seem to never arrive such as a house sale completion . Frustration is starting to wear thin now.

Again more buys than sells, low volume yet still they’re dropping the share price . Looks like they’re trying to scare people into selling to get hold of stock before next week, they’re not having mine.

Anticipating an RNS next week could see us end up in the blue today, news will come in the next week or two, what the sp does between now and then does not concern me, Dr Als confidence exuded in the Vox interview and that’s good enough for me.

Great RNS this morning, looking forward to full year results 1st April. GLA

One good sign is that the shares are easy to sell, I’ve just done a dummy sale of 1million shares and was offered above the bid, the sp will bounce back as fast as it’s fallen. As soon as we get some decent news, I am quite happy to wait until then, we shouldn’t have too long to wait.

Not only the market but both private and institutional investors require news , frustration is now effecting the share price , as someone else has said it is the job of the board and the CEO to give confidence to the SP , simply starving investors of information is having an adverse effect on the SP.

More buyers than sellers , yet still the sp is marked down. With news imminent within the next two weeks and most likely within a week. Dr Al exuded confidence in his Vox interview so my view is the drop in the sp is purely mm’s trying to trigger stop losses and panic sellers. Hold on , it will happen soon.

Come on Bloe give us some decent news , news is due imminently and it’s needed to support the sp which in turn will reward employees, suppliers and long term holders . Patience is wearing thin now, PH’s credibility is destroyed and is having a detrimental effect on confidence in the company and the share price. Good news may restore his credibility in the city for his past failures to hit his own deadlines.

Pfizer

I agree we will be on Phizers radar without doubt, it would be better for them to move now at this stage for value.

As this gathers momentum and new investors who see the massive worldwide potential and obvious takeover material despite the recent rise (no pun intended) this has got a lot further to go on speculation alone.

The Yanks will be all over this , this afternoon. There are investors in the US who invest purely on FDA decisions. GLA

The resurgence of the South Africa variant of COVID in Europe which potentially could spread to the UK highlights the urgency for the Avacta LFT especially when coupled with the sluggish roll out of the vaccine in Europe and the delays with Serum production. Avacta really does hold the key to opening up the European and UK economies where testing is going to prove its worth for the foreseeable future.

Sep 2020 7:00 am RNS Interim Results for Six Months Ended 30 June 2020
24th Sep 2020 7:00 am RNS Operational and Corporate Update
18th Jun 2020 1:14 pm RNS Result of AGM
18th Jun 2020 7:00 am RNS West Rustavi EPF Update and Appointment of EPI
18th May 2020 7:00 am RNS Posting of Annual Report & Accounts; Notice of AGM
30th Apr 2020 6:29 pm RNS Audited results for the 18m period ending 31 12 19
7th Apr 2020 7:00 am RNS Operations Update
Are these more or less the timings we can expect this year, if so we can expect an operations update in a couple of week followed by the annual results at the end of April, with all that we know and can expect the an SP of between 6-10p can be expected. I don’t think the market is going to wait for these RNS’s, I think the clever money will start filtering through into the share price form next week before any official news. GLA

I’ve just bought in this morning as I believe that PRM are supplying Avacta , if this is correct then PRM are flying below the radar and the shares look very cheap if you believe Avacta are on the verge of something very big.

Does anyone know if Proteome Sciences are part of the primary supply chain to Actava’s Affirmer proteins ? If so their shares are seriously flying below the radar. Worth a look , Thanks Rebecca.